We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
Product News

Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis

Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
Product News

Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Nanion acquires the well-established SURFE2R technology, allowing measurements of transporter protein activity and function.

The SURFE2R technology is an excellent enhancement to Nanion’s existing products which until now covered ion channels and nanopores.

Nanion Technologies is one of the leading providers of high quality automated patch clamp systems.

Nanion’s efficient and versatile products drastically improve the data output in patch clamp-based ion channel screening, safety testing and scientific research.

Since 2003, Nanion has launched three automated patch clamp platforms, the Port-a-Patch (2003), the Patchliner (2006), the SyncroPatch 96 (2010), and recently introduced the Orbit 16 - a device for parallel bilayer recordings.

Existing products target ion channels and nanopores in cell- and cell-free membranes for highly detailed information about kinetics, function, and compound pharmacology.

Dr. Niels Fertig, CEO of Nanion Technologies, says: “By acquiring the SURFE2R technology developed by IonGate / Scientific Devices Heidelberg, Nanion enters yet another market segment. It is an excellent addition to our product portfolio and a unique platform since it allows direct measurements of transporter activity and function. Further on, the platform has been validated with a wide variety of membrane preparations ranging from bacteria to native cells and cell lines. With this acquisition, Nanion becomes a one-stop-shop for functional membrane protein analysis, extending its product portfolio from screening instrumentation for ion channels and nanopores to now also include transporter proteins.”

The SURFE2R product line will be launched during the second half of 2012.

Advertisement